147 related articles for article (PubMed ID: 35521410)
21. The in vitro dissolution of theophylline from different types of hard shell capsules.
Podczeck F; Jones BE
Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
[TBL] [Abstract][Full Text] [Related]
22. Evaluation and Characterization of Hard-Shell Capsules Formulated by Using Goatskin Gelatin.
Zilhadia Z; Harahap Y; Jaswir I; Anwar E
Polymers (Basel); 2022 Oct; 14(20):. PubMed ID: 36297993
[TBL] [Abstract][Full Text] [Related]
23. Industrial Manufacture of Enteric Hard Capsules Using Novel Formulations Based on Hypromellose Phthalate/Gelatin and Investigation of Pantoprazole Release.
Kalmer RR; Haddadan MM; Azizi M; Ghanbari M; Samandarian D; Sadjadinia A; Ramezanalizadeh H; Karimi A; Golizadeh M
ACS Omega; 2023 Mar; 8(12):11293-11303. PubMed ID: 37008088
[TBL] [Abstract][Full Text] [Related]
24. Determination of the optimal amount of water in liquid-fill masses for hard gelatin capsules by means of texture analysis and experimental design.
Kuentz M; Röthlisberger D
Int J Pharm; 2002 Apr; 236(1-2):145-52. PubMed ID: 11891078
[TBL] [Abstract][Full Text] [Related]
25. Moisture diffusion and permeability characteristics of hydroxypropylmethylcellulose and hard gelatin capsules.
Barham AS; Tewes F; Healy AM
Int J Pharm; 2015 Jan; 478(2):796-803. PubMed ID: 25526672
[TBL] [Abstract][Full Text] [Related]
26. Novel hard capsule prepared by tilapia (Oreochromis niloticus) scale gelatin and konjac glucomannan: Characterization, and in vitro dissolution.
Liu Y; Li B; Zhang K; Li J; Hou H
Carbohydr Polym; 2019 Feb; 206():254-261. PubMed ID: 30553320
[TBL] [Abstract][Full Text] [Related]
27. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
28. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
Ciper M; Bodmeier R
Eur J Pharm Biopharm; 2006 Feb; 62(2):178-84. PubMed ID: 16260126
[TBL] [Abstract][Full Text] [Related]
29. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide.
Hong SS; Lee SH; Lee YJ; Chung SJ; Lee MH; Shim CK
J Control Release; 1998 Feb; 51(2-3):185-92. PubMed ID: 9685916
[TBL] [Abstract][Full Text] [Related]
30. Carbopol 934-Sodium Alginate-Gelatin Mucoadhesive Ondansetron Tablets for Buccal Delivery: Effect of pH Modifiers.
Kotagale NR; Patel CJ; Parkhe AP; Khandelwal HM; Taksande JB; Umekar MJ
Indian J Pharm Sci; 2010 Jul; 72(4):471-9. PubMed ID: 21218058
[TBL] [Abstract][Full Text] [Related]
31. Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.
Marchais H; Cayzeele G; Legendre JY; Skiba M; Arnaud P
Eur J Pharm Sci; 2003 Jun; 19(2-3):129-32. PubMed ID: 12791415
[TBL] [Abstract][Full Text] [Related]
32. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
Curatolo W; Liu P; Johnson BA; Hausberger A; Quan E; Vendola T; Vatsaraj N; Foulds G; Vincent J; Chandra R
Pharm Res; 2011 Jul; 28(7):1531-9. PubMed ID: 21331473
[TBL] [Abstract][Full Text] [Related]
33. Application of the UV laser printing technique to soft gelatin capsules containing titanium dioxide in the shells.
Hosokawa A; Kato Y
Drug Dev Ind Pharm; 2012 Mar; 38(3):351-6. PubMed ID: 22050221
[TBL] [Abstract][Full Text] [Related]
34. Development and Characterisation of Modified Release Hard Gelatin Capsules, Based on In Situ Lipid Matrix Formation.
Vasvári G; Csontos B; Sovány T; Regdon G; Bényei A; Váradi J; Bácskay I; Ujhelyi Z; Fehér P; Sinka D; Nguyen TLP; Vecsernyés M; Fenyvesi F
AAPS PharmSciTech; 2018 Oct; 19(7):3165-3176. PubMed ID: 30136176
[TBL] [Abstract][Full Text] [Related]
35. Characteristic Comparison of an Intraoral Thin Film Containing Astaxanthin Nanoemulsion Using Sodium Alginate and Gelatin Polymers.
Nurdianti L; Rusdiana T; Sopyan I; Putriana NA; Aiman HR; Fajria TR
Turk J Pharm Sci; 2021 Jun; 18(3):289-295. PubMed ID: 34157818
[TBL] [Abstract][Full Text] [Related]
36. Soft gelatin capsules II: Oxygen permeability study of capsule shells.
Hom FS; Veresh SA; Ebert WR
J Pharm Sci; 1975 May; 64(5):851-7. PubMed ID: 1151660
[TBL] [Abstract][Full Text] [Related]
37. Alginate/Fish Gelatin-Encapsulated
Hadidi M; Majidiyan N; Jelyani AZ; Moreno A; Hadian Z; Mousavi Khanegah A
Foods; 2021 Sep; 10(9):. PubMed ID: 34574325
[TBL] [Abstract][Full Text] [Related]
38. The effect of poloxamer viscosity on liquid-filling of solid dispersions in hard gelatin capsules.
Kattige A; Rowley G
Drug Dev Ind Pharm; 2006 Sep; 32(8):981-90. PubMed ID: 16954111
[TBL] [Abstract][Full Text] [Related]
39. Oral controlled release formulation for highly water-soluble drugs: drug--sodium alginate--xanthan gum--zinc acetate matrix.
Zeng WM
Drug Dev Ind Pharm; 2004 May; 30(5):491-5. PubMed ID: 15244084
[TBL] [Abstract][Full Text] [Related]
40. In vivo evaluation of an indomethacin monolithic, extended zero-order release hard-gelatin capsule formulation based on saturated polyglycolysed glycerides.
Vial-Bernasconi AC; Buri P; Doelker E; Beyssac E; Duchaix G; Aiache JM
Pharm Acta Helv; 1995 Dec; 70(4):307-13. PubMed ID: 8765697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]